After more than 10 years of continuous growthMCTis now operating in 36 countries acrossMENA&Africa.

Proud to be the largest regionalCROof MENA!
Looking forward to continuedexpansionandgrowth.

During the Sickle Cell Awareness month MCT is proud to contribute to the research to find a treatment for sickle cell disease with hundreds of patients recruited to date.

MCT is grateful to Pr. Olayemi and his team at Korle-Bu site in Ghana, for recruiting their first patients on a SCD study.

No doubt the Korle-Bu site will significantly contribute to the success of this study!

MCT is pleased to announce the recruitment of the first patients at Kintampo site in Ghana, on a promising SCD study. Thanks to Dr. Kaali and his great team, who have made it all possible!

MCT is currently involved in 5 COVID-19 clinical trials across Africa in 10 countries, (Tunisia, Rwanda, Ghana, Uganda, Kenya, Mozambique, Zimbabwe, Mali, Nigeria, Malawi) and close to 30 sites, aiming at more than 20,000 patients to be vaccinated.

A big thanks to all the PIs and site staff who contribute by their hard work and dedication to make Africa and the world safer.

MCT has been working on a challenging and exciting Lassa Fever study in Ghana.

We’re taking a moment here to congratulate Prof. Koram and his team from the Noguchi MIMR site in Ghana, for their excellent work.

136 patients randomized so far. Keep this amazing pace!

MCT is proud to be successfully running a Polio Vaccine study with 1,119 patients randomized within 5 months and targeting around 3,000 patients by March 2022.

MCT would like to congratulate Dr Jahanjir Hossain and his team for completing the first cohort of the study.

20200904 MCT Insights_Plan to make HCV disappear in Egypt

MCT attended PCMG 2020 live on June 24-26. This was an opportunity to experience remote conference on Zoom and like for previous conferences to exchange with outsourcing and procurement professionals working in R&D across Pharma industry.